BioCentury | Oct 10, 2013
Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms MicroRNA and small interfering RNA combination therapy for cancer Mouse and cell culture studies suggest combined use of miRNA and siRNA against a target could...
BioCentury | Jan 7, 2010
Distillery Therapeutics

Indication: Cancer

...Licensing status Publication and contact information Cancer Brain cancer Chr19q13.41 microRNA cluster (C19MC); microRNA-517c (miR-517c); miR-520g...
...of C19MC miRNAs (p<0.0001). Mice that received human medulloblastoma cells expressing C19MC miRNAs miR-517c or miR-520g...
BioCentury | Mar 20, 2008
Markers

Micro Management

In the past four years, at least two biotechs have released tests that use mRNA-based gene signatures to predict the likelihood of breast cancer recurrence. Now, research is emerging that suggests microRNAs could also have...
BioCentury | Jan 31, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Metastatic cancer miR-373; miR-520c; CD44 In vitro and in vivo studies suggest that miR-373 and miR-520c could be used as targets...
Items per page:
1 - 4 of 4